Please ensure Javascript is enabled for purposes of website accessibility

A Brief History of WellPoint's Returns

By Motley Fool Staff – Updated Apr 6, 2017 at 5:17PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Understanding how you got from A to B.

Despite constant attempts by analysts and the media to complicate the basics of investing, there are only three ways a stock can create value for shareholders:

  1. Dividends.
  2. Earnings growth.
  3. Changes in valuation multiples.

In this series, we drill down on one company's returns to see how each of those three has played a role over the past decade. Step on up, WellPoint (NYSE: WLP).

WellPoint shares returned 180% over the last decade. How'd they get there?

Dividends helped only marginally. Without dividends, shares returned 177% over the past 10 years.

Earnings growth was surprisingly strong. WellPoint's normalized earnings per share grew by an average of 16.9% a year from 2001 until today. Most health insurers have enjoyed a booming decade -- competitors UnitedHealth Group (NYSE: UNH) and Humana (NYSE: HUM) both grew earnings by double-digit rates as well.

And have a look at WellPoint's valuation multiple:

Source: S&P Capital IQ.

Like so many large-cap companies, WellPoint was overvalued a decade ago. Falling valuations ever since have kept shareholder returns lower than they otherwise would be, preventing part of the company's earnings growth from turning into shareholder returns. Put simply, the market doesn't value $1 of WellPoint's earnings as much today as it did in the past. Indeed, WellPoint was an example of a company I once pointed out that doubled earnings while shares went nowhere.

At 10 times earnings, that could change going forward. Shares could easily be considered cheap at current prices. The past decade has been the story of growing earnings and falling valuations. The coming decade could still see strong earnings growth, but stable or even rising valuations, letting far more of WellPoint's internal performance translate into shareholder returns.

Why is this stuff worth paying attention to? It's important to know not only how much a stock has returned, but where those returns came from. Sometimes earnings grow, but the market isn't willing to pay as much for those earnings. Sometimes earnings fall, but the market bids shares higher anyway. Sometimes both earnings and earnings multiples stay flat, but a company generates returns through dividends. Sometimes everything works together, and returns surge. Sometimes nothing works and they crash. All tell a different story about the state of a company. Not knowing why something happened can be just as dangerous as not knowing that something happened at all.

Fool contributor Morgan Housel doesn't own shares in any of the companies mentioned in this article. Follow him on Twitter, where he goes by @TMFHousel. The Motley Fool owns shares of UnitedHealth Group. Motley Fool newsletter services have recommended buying shares of WellPoint and UnitedHealth Group and creating a diagonal call position in UnitedHealth Group. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Elevance Health Inc. Stock Quote
Elevance Health Inc.
ELV
$453.85 (-1.95%) $-9.03
UnitedHealth Group Incorporated Stock Quote
UnitedHealth Group Incorporated
UNH
$513.61 (-0.74%) $-3.85
Humana Inc. Stock Quote
Humana Inc.
HUM
$486.90 (-1.42%) $-7.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.